FemTech
Funding & Empowering Female Entrepreneurs
Our Strategic Advantage
Our Position
The CEV Women’s Health & Technology Fund is a $5 million early-stage venture capital fund dedicated to investing in high-growth, female-centric healthcare and technology companies across the United States, with a strategic emphasis on the Interior Innovation Corridor.
FemTech Market Outlook
FemTech market is valued around roughly $60–$66 billion in 2025 driven by rising demand for women’s health technologies, VC funding into FemTech startups remains and underserved community (historically $2 billion annually). CEV aims to help flip this disparity.
FemTech Fund Snapshot
Fund: $5M (Likely to Oversubscribe)
The FemTech fund will target venture scale health & wellness technology. The fund managers expect returns with a 5 - 10x MOIC. All CEV funds expect 10 year fund life and provide quarterly and annual reports.
Catherine Aglipay
CEV FemTech General Partner
Catherine is a seasoned entrepreneur and venture fund builder. She served as the head of portfolio management at for the last decade at Goldman Sachs. Though successful at venture, her passion is women’s health technologies and empowering companies who’s mission to advance human health is as strong as their balance sheet.
